moneyheap
VBK · Analysis updated Nov 10, 2026, 6:00 PM ET
Why is Vanguard Morningstar Small-Cap Growth ETF (VBK) stock moving?
No news items in the 14-day window or SEC filings in the 45 days before the current date relate to VBK, so this view rests only on price and volume. VBK closed at $329.15 on Nov 10, about 3% below its Oct 29 close of $338.95 and roughly flat over the 30-day window. The main event was the Nov 5 session, when the ETF fell from $334.13 to $316.15 (about -5.4%) on volume of 531,718, roughly 3.5 times the typical level near 150,000 shares, and the trade count jumped to 9,396. Price then recovered in steps: $320.29 on Nov 6, then $332.09 on Nov 9 on higher volume, and $329.15 on Nov 10 on lighter volume. The $316 area marks the recent low and the $339-340 area the recent high. The selloff has no identified cause in the supplied data, so it is unclear whether it reflects a broad small-cap move or an ETF-specific event. With no catalyst ahead and volume now back near normal, the evidence leans neutral.
About Vanguard Morningstar Small-Cap Growth ETF
Vanguard Morningstar Small-Cap Growth ETF, formerly the Vanguard Small-Cap Growth ETF, is a low-cost index fund that holds about 550 smaller US companies picked for their growth traits. It launched in 2004 and has roughly $22 billion in ETF assets. It now follows a Morningstar index instead of the CRSP index it used before.
How the fund works
The fund tracks the Morningstar US Small Cap Growth Index passively, owning every stock in the index (full replication). Each stock is weighted by its market value, and the holdings are rebalanced every quarter. The expense ratio is about 0.05% a year, and dividends, which are small (yield under 0.5%), are paid quarterly. The top 10 holdings make up only about 11–12% of the fund. Its biggest sectors are technology, industrials and healthcare. Small growth stocks tend to swing more than large caps, and the fund uses no leverage.
What usually moves VBK
- Interest rates and Fed policy expectations
- US economic growth outlook
- Investor appetite for risk and growth stocks
- Tech and biotech sector sentiment
- Credit conditions for smaller companies